Adara Wright News Today

Federated Hermes Inc. boosted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 34.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 61,728 shares of the medical research company’s stock after purchasing an additional 15,871 shares during the period. Federated Hermes […]

Mutual of America Capital Management LLC cut its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 4.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,921 shares of the medical research company’s stock after selling 148 shares during the […]

Grantham Mayo Van Otterloo & Co. LLC raised its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 6.9% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 82,443 shares of the medical research company’s stock after purchasing an additional 5,339 shares during the […]

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) posted its earnings results on Thursday. The medical research company reported $3.10 EPS for the quarter, topping analysts’ consensus estimates of $2.93 by $0.17, Briefing.com reports. The company had revenue of $681.18 million for the quarter, compared to the consensus estimate of $685.00 million. Bio-Rad Laboratories had a […]

Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report)’s stock price gapped up prior to trading on Friday after the company announced better than expected quarterly earnings. The stock had previously closed at $328.73, but opened at $350.00. Bio-Rad Laboratories shares last traded at $353.18, with a volume of 85,007 shares changing hands. The medical research […]

Clearstead Advisors LLC decreased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 35.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 120 shares of the medical research company’s stock after selling 67 shares during the period. […]

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) have been assigned a consensus recommendation of “Buy” from the four analysts that are currently covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have issued a report on the […]

Los Angeles Capital Management LLC decreased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 74.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,667 shares of the medical research company’s stock after selling 10,614 shares during the quarter. Los Angeles Capital […]

Winslow Asset Management Inc. boosted its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 2.7% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 21,443 shares of the medical research company’s stock after purchasing an additional 568 shares during the period. Bio-Rad Laboratories comprises approximately 1.8% […]

FDx Advisors Inc. acquired a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 598 shares of the medical research company’s stock, valued at approximately $214,000. A number of other hedge funds and […]